Comparison of Two Surgical Techniques for Open Subpectoral Biceps Tenodesis

April 21, 2026 updated by: Michael T. Freehill, Stanford University

Comparison of Bicep Tendon Migration Between Two Techniques for Open Subpectoral Biceps Tenodesis

Participants who are indicated for an open biceps tenodesis procedure will be recruited to join the study. The participant will undergo the standard biceps tenodesis procedure using either one standard anchor or two mini anchors by the study staff surgeon. Both techniques are safe and considered standard of care. The participant will be randomized to either group. After the biceps are secured in the standard fashion, a sterile radiolucent bead will be applied to the tendon. The participant will undergo xray imaging in the post-anesthesia care unit to determine a baseline measurement of the location of the radiolucent bead. The participant will then undergo further xray imaging at their 2 week and 6 month-up visits.

Study Overview

Status

Withdrawn

Conditions

Detailed Description

Participants who are indicated for an open biceps tenodesis procedure will be recruited to join the study. The participant will undergo the standard biceps tenodesis procedure using either one standard anchor or two mini anchors by the study staff surgeon. Both techniques are safe and considered standard of care. The participant will be randomized to either group. After the biceps are secured in the standard fashion, a sterile radiolucent bead will be applied to the tendon. This will allow for measurements to be made on xray imaging in the post-operative period. The placement of the clip is the only experimental portion of the procedure. The participant will undergo xray imaging in the post-anesthesia care unit to determine a baseline measurement of the location of the radiolucent bead. The participant will then undergo further xray imaging at their 2 week and 6 month-up visits. These visits are standard visits for the participant who undergo this procedure.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Stanford, California, United States, 94305
        • Stanford University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participant age 18 and above who would otherwise indicated for biceps tenodesis due to biceps tendinopathy with or without associated rotator cuff pathology

Exclusion Criteria:

  • Participant under the age of 18 will be excluded from the study as there is no indication to perform this procedure in children.
  • Any participant who had previous surgery or injury to their biceps or biceps tendon will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: One Anchor
Participant will receive one standard anchor during standard biceps tenodesis procedure
Participant will receive one standard anchor
Experimental: Two Mini Anchors
Participant will receive two mini anchors during standard biceps tenodesis procedure
Participant will receive two mini anchors

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sterile radiolucent bead location distance
Time Frame: Baseline, 2-weeks, 6-months
Sterile radiolucent bead location will be measured during all 3 xrays. Comparison of these measurements will be between the two groups.
Baseline, 2-weeks, 6-months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant Reported Outcome VAS
Time Frame: 2-weeks, 6-months
Change in Visual Analog Scale (VAS); minimum 0, maximum 10, higher score is a worse outcome
2-weeks, 6-months
Participant Reported Outcome Constant
Time Frame: 2-weeks, 6-months
Constant Score; minimum 0, maximum 100, higher score is a better outcome
2-weeks, 6-months
Participant Reported Outcome ASES
Time Frame: 2-weeks, 6-months
American Shoulder Elbow Score (ASES); minimum 0, maximum 100, higher score is a better outcome
2-weeks, 6-months
Participant Reported Outcome SSV
Time Frame: 2-weeks, 6-months
Subjective Shoulder Value (SSV); minimum 0, maximum 100, higher score is a better outcome
2-weeks, 6-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Freehill, MD, Stanford University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

January 21, 2025

First Submitted That Met QC Criteria

January 21, 2025

First Posted (Actual)

January 28, 2025

Study Record Updates

Last Update Posted (Actual)

April 24, 2026

Last Update Submitted That Met QC Criteria

April 21, 2026

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 77635

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bicep Tenodesis

Clinical Trials on One Anchor

Subscribe